Everything below concerns incretin. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | Peptide backbone with a C18 fatty diacid side chain |
| Molecular weight | Approximately 4113 Da | Consistent with a 31-residue peptide plus linker |
| Appearance | White to off-white powder | Lyophilized solid; hygroscopic if left open |
| Solubility class | Sparingly soluble to soluble in water | Varies with pH and ionic strength |
| Typical analytical method | Reversed-phase HPLC with UV detection | Often paired with mass spectrometry for identity |
Routine characterisation of the peptide relies on reversed-phase high-performance liquid chromatography, often paired with ultraviolet detection near 214 nanometres. Related substances such as deamidated, oxidised, and truncated sequences elute at characteristic positions and are quantified by area percentage. Electrospray ionisation mass spectrometry confirms the molecular mass and can resolve some closely related variants. Peptide mapping after enzymatic digestion provides sequence-level verification and is useful when a full identity profile is required. Method parameters such as column chemistry, gradient, and mobile-phase pH influence the separation and must be reported alongside results.
Material described as research-grade is not necessarily manufactured to pharmaceutical standards, and purity figures depend on the method used to obtain them. A certificate of analysis states the measured purity, the analytical technique, and the batch identifier, but the underlying data are not always included. Independent testing by a second laboratory is a common way to confirm identity and purity. Uncertainties remain about how storage history affects long-term stability, and about how well results from one laboratory transfer to another. Documentation of handling conditions supports comparison between batches.
As a peptide, semaglutide is sensitive to conditions that break amide bonds or modify side chains. Deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation are the main degradation routes described in published stability work. Rate depends strongly on pH, buffer species, ionic strength, temperature and exposure to light. Formulators therefore choose a defined solution pH and often add excipients such as phosphate buffer, propylene glycol and phenol, each of which plays a separate role in pH control, tonicity or preservation.
Storage guidance for the finished injectable product distinguishes the unused state from the in-use state. Before first use, pens are kept refrigerated between 2 and 8 degrees Celsius, protected from light, and never frozen, since freezing can disrupt the peptide or the device. After first use, label instructions in several markets permit storage at room temperature up to about 30 degrees Celsius for a limited number of days. Solid research-grade material is normally held at or below minus 20 degrees Celsius, often with desiccant, and allowed to equilibrate before opening.
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nm is the standard purity method, reported as area percent. Mass spectrometry, usually with electrospray ionisation, confirms identity and reveals covalent modifications. Size-exclusion chromatography quantifies aggregates and fragments. Peptide mapping after enzymatic digestion localises changes to specific sequence regions. Circular dichroism and infrared spectroscopy report on secondary structure, while light scattering tracks particle formation in liquid formulations. No single technique captures every quality attribute.
Wetsuits are economical and used where the water temperature is not too low - more than about 65 °F (18 °C), the diver will not be spending too long in the water, and the water is reasonably clean. Dry suits are better thermal protection than most wetsuits, and isolate the diver from the environment more effectively than other exposure suits. When diving in contaminated water, a drysuit with integral boots, sealed dry gloves and a helmet sealed directly to the suit provides the best environmental isolation. The suit material must be selected to be compatible with the expected contaminants. Thermal undersuits can be matched to the expected water temperature. Hot water suits provide active warming which is particularly suitable for use with helium based breathing gases. Heated water is provided from the surface through a hose in the umbilical, and water flow can be adjusted to suit the diver's needs. Heated water continuously flows into the suit and is distributed by perforated internal tubes down the front and back of the torso and along the limbs.
== Chemistry == The original synthesis at Janssen Pharmaceutica resulted in the preparation of a racemic mixture of two enantiomers, whose hydrochloride salt was reported to have a melting point of 264–265 °C; the free base of the racemate has a melting point of 87–89 °C. The racemic mixture is referred to as "tetramisole" - levamisole refers only to the levorotatory enantiomer of tetramisole.
Progestogens are the precursors of all other human steroids, and all human tissues which produce steroids must first convert cholesterol to pregnenolone. This conversion is the rate-limiting step of steroid synthesis, which occurs inside the mitochondrion of the respective tissue. The conversion is catalyzed by the mitochondrial P450scc system. Cortisol, corticosterone, aldosterone are produced in the adrenal cortex. Estradiol, estrone and progesterone are made primarily in the ovary, estriol in placenta during pregnancy, and testosterone primarily in the testes (some testosterone may also be produced in the adrenal cortex). Estradiol is converted from testosterone directly (in males), or via the primary pathway DHEA – androstenedione – estrone and secondarily via testosterone (in females). Stromal cells have been shown to produce steroids in response to signaling produced by androgen-starved prostate cancer cells. Some neurons and glia in the central nervous system (CNS) express the enzymes required for the local synthesis of pregnenolone, progesterone, DHEA and DHEAS, de novo or from peripheral sources.
He wakes up disoriented and alarmed to find himself naked, weak, and hairless in a pod full of what can be assumed to be an artificial amniotic fluid. He also discovers that he is connected to a series of thick cables, by way of a number of plugs that are grafted to his body, including one plugged directly into the base of his skull, which is later explained as the means through which his mind was connected to the Matrix. Upon his "birthing" into the real world, he is discovered by a machine that grabs him by the neck and removes all of his plugs and cables before flushing him out of his fluid tank down into the cold sewers below the Earth's surface. Neo is rescued by Morpheus, and his body is healed of the effects of his atrophy incurred while inside the pod. Once Neo regains consciousness and mobility, Morpheus tells Neo the truth about the Matrix; it is a simulated world to which humans are connected, "a prison for your mind", as stated by Morpheus, while unknown to them, their bodies are used as a power source for a race of sentient machines that, ironically, mankind created. He also tells Neo about the One, a human with the power to manipulate the Matrix, who has been foretold to end the war between humans and machines, and says that he believes Neo is the One. The next day, Neo begins his "training" and eventually masters many forms of combat, as well as vehicle and weapons operations, by having various training programs uploaded directly into his brain.
== Role in wound healing == A transepithelial potential (TEP) is created by a difference in ion concentrations across a tissue barrier in the body. In humans, a gradient exists between the outermost and innermost layers of skin across the entire body. This gradient can range from 10mV to 60mV, depending on which part of the body is measured. The potential is created by epithelial cells, which pump Cl− ions out of the skin through the apical membrane and transport Na+ ions to the basal side of the epithelium. This is supported by an experiment in which Na+ and Cl− transport was increased by addition of AgNO3, and a corresponding increase in membrane potential was observed. Furosemide, a Cl− efflux inhibitor, also decreased the strength of the field in corneal cells. These potentials are maintained elsewhere on the body, such as in the GI, urinary, and respiratory ducts, as well as the corneal epithelium. When the epithelium is pierced by some kind of wound, the barrier which establishes the electric potential has been removed, and so the TEP cannot be maintained. This creates a lateral EF, running from intact epithelium toward the edges of the wound. These wound EFs last as long as the wound takes to heal, and are involved in guiding various types of cells toward the injury in order to facilitate recovery These lateral fields arise instantaneously upon disruption of the epithelium and gradually increase to their maximum strength. The current strength then declines but is maintained throughout the healing process.
Sources: en.wikipedia.org
Hashish (also spelled hasheesh, hashisha, or simply hash) is a concentrated resin cake or ball produced from pressed kief, the detached trichomes and fine material that falls off cannabis fruits, flowers and leaves, or from scraping the resin from the surface of the plants and rolling it into balls. It varies in color from black to golden brown depending upon the purity and variety of cultivar it was obtained from. It can be consumed orally or smoked, and is also vaporized, or 'vaped'. The term "rosin hash" refers to a high-quality, solventless product obtained through heat and pressure.
Physical activity can be related to a person's professional activities, non-work related daily activities like walking or cycling, or it can be in the form of activities such as recreation or team sports. The specific type of activity can be tailored to populations such as children, pregnant women, and elderly adults. Tailored activity to one's fitness level also encourages the body to heal properly and prevent any injuries as a result of exercise. Physical inactivity leads to less energy expenditure and is a factor that impacts obesity rates in both children and adults. Physical inactivity has become a worldwide concern since inactivity also elevates the risk of heart disease. With a regular active lifestyle it can reduce the risk for noncommunicable diseases like diabetes, heart disease, and dyslipidemia (high cholesterol). Physical activity not only reduces the risk of noncommunicable diseases, but it also can benefit the body such as improving sleep patterns, reducing both anxiety and depression, and of course, helps weight loss and weight management.
Another method to be considered is surface plasmon resonance (SPR). SPR can detect binding of label free molecules on the surface of a chip. If the desired protein is an antibody, binding can be translated directly to the activity of the protein. One can express the active concentration of the protein as the percent of the total protein. SPR can be a powerful method for quickly determining protein activity and overall yield. It is a powerful technology that requires an instrument to perform.
"In particular, wild boars in southern Bavaria are repeatedly found to have a very high radioactive contamination of over 10,000 Becquerel/kg. The limit is 600 Becquerel/kg. For this reason, the Bavarian Consumer Center advises against eating wild boar from the Bavarian Forest and south of the Danube too often. Whoever buys wild boar from a hunter, should ask for the measurement protocol."
Sources: en.wikipedia.org
It is given either as a once-weekly subcutaneous injection or as an oral tablet taken once daily. The two forms use different absorption strategies, so they are not interchangeable on a milligram-for-milligram basis.
Structural modifications, including a fatty acid side chain and non-natural amino acid substitutions, slow enzymatic breakdown and promote albumin binding. These changes support once-weekly dosing rather than twice-daily administration.
The pathways involving insulin, glucagon, gastric emptying, and appetite signaling are well described. How much each pathway contributes to weight reduction in a given person is not fully established.
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.